1. Home
  2. TCRT vs PTIX Comparison

TCRT vs PTIX Comparison

Compare TCRT & PTIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TCRT
  • PTIX
  • Stock Information
  • Founded
  • TCRT 1998
  • PTIX 1994
  • Country
  • TCRT United States
  • PTIX United States
  • Employees
  • TCRT N/A
  • PTIX N/A
  • Industry
  • TCRT Biotechnology: Pharmaceutical Preparations
  • PTIX Biotechnology: Pharmaceutical Preparations
  • Sector
  • TCRT Health Care
  • PTIX Health Care
  • Exchange
  • TCRT Nasdaq
  • PTIX Nasdaq
  • Market Cap
  • TCRT 2.5M
  • PTIX 2.0M
  • IPO Year
  • TCRT N/A
  • PTIX 2016
  • Fundamental
  • Price
  • TCRT $2.63
  • PTIX $0.22
  • Analyst Decision
  • TCRT
  • PTIX
  • Analyst Count
  • TCRT 0
  • PTIX 0
  • Target Price
  • TCRT N/A
  • PTIX N/A
  • AVG Volume (30 Days)
  • TCRT 1.5M
  • PTIX 10.5M
  • Earning Date
  • TCRT 05-14-2025
  • PTIX 05-14-2025
  • Dividend Yield
  • TCRT N/A
  • PTIX N/A
  • EPS Growth
  • TCRT N/A
  • PTIX N/A
  • EPS
  • TCRT N/A
  • PTIX N/A
  • Revenue
  • TCRT $10,000.00
  • PTIX N/A
  • Revenue This Year
  • TCRT $5,680,500.00
  • PTIX N/A
  • Revenue Next Year
  • TCRT N/A
  • PTIX N/A
  • P/E Ratio
  • TCRT N/A
  • PTIX N/A
  • Revenue Growth
  • TCRT 100.00
  • PTIX N/A
  • 52 Week Low
  • TCRT $1.31
  • PTIX $0.18
  • 52 Week High
  • TCRT $14.20
  • PTIX $1.87
  • Technical
  • Relative Strength Index (RSI)
  • TCRT 54.55
  • PTIX 42.85
  • Support Level
  • TCRT $2.27
  • PTIX $0.21
  • Resistance Level
  • TCRT $2.93
  • PTIX $0.25
  • Average True Range (ATR)
  • TCRT 0.40
  • PTIX 0.03
  • MACD
  • TCRT -0.05
  • PTIX -0.01
  • Stochastic Oscillator
  • TCRT 33.04
  • PTIX 9.82

About TCRT Alaunos Therapeutics Inc.

Alaunos Therapeutics Inc is a clinical-stage cellular immuno-oncology company dedicated to the treatment of solid tumors through adoptive TCR-T cell therapy. It strikes cancer at its core by engineering cell therapies that target Neoantigens arising from genomic mutations.

About PTIX Protagenic Therapeutics Inc.

Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression, and neurodegenerative disorders by using peptide-based and brain-active therapeutics. The company's lead compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. It has also created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders.

Share on Social Networks: